Physician profile
German Larrain
NPI 1508845090
$38,153.63
in general payments reported to CMS, 2019-2025
33 companies · $8,767 in 2025
The $8,767 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,191 · 2020: $770 · 2021: $2,168 · 2022: $7,077 · 2023: $7,010 · 2024: $8,171 · 2025: $8,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $11K · Consulting Fee: $152 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,177.67 |
| Food and Beverage | $11,488.87 |
| Consulting Fee | $152.32 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,176.35 | 2019-2025 | Amplatzer Amulet, Epic, Navitor |
| Boston Scientific Corporation | $5,149.37 | 2019-2025 | General - Vascular Access, Watchman Flx, General - Structural Heart |
| Edwards Lifesciences Corporation | $4,768.48 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Penumbra, INC. | $4,679.86 | 2024-2025 | Indigo System |
| Medtronic Vascular, INC. | $2,946.25 | 2019-2020 | |
| Heartflow, INC. | $2,539.84 | 2023-2024 | Ffrct |
| Inari Medical, INC. | $1,882.90 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $1,564.68 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Ge Healthcare | $916.06 | 2021-2022 | |
| Abiomed | $732.86 | 2025 | |
| Atricure, INC. | $463.98 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $443.37 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $322.46 | 2019-2025 | |
| Pfizer INC. | $290.74 | 2019-2022 | |
| Shockwave Medical, INC | $289.53 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $262.08 | 2023-2025 | Repatha, Repatha |
| Siemens Medical Solutions USA, INC. | $251.20 | 2024-2025 | Biograph Vision 600 (8 Ring/64 Ct) |
| Artivion, INC. | $217.44 | 2021-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cryovalve Sg Pulmonary Human Heart Valve |
| Novo Nordisk INC | $210.12 | 2022-2024 | Wegovy |
| Angiodynamics, INC. | $206.79 | 2021-2023 | Angiovac |
| Regeneron Healthcare Solutions, INC. | $126.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Philips North America LLC | $117.71 | 2024 | (P77) Azurion 7 M20 |
| Daxor Corporation | $109.89 | 2024 | Bva-100 |
| Livanova USA, INC. | $100.97 | 2022-2023 | Lifesparc |
| Stryker Corporation | $93.36 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Janssen Pharmaceuticals, INC | $77.07 | 2021 | |
| Merck Sharp & Dohme LLC | $65.66 | 2024 | Winrevair |
| Getinge USA Sales, LLC | $23.51 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw German Larrain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.